Ingevity Lifts FY26 EBITDA Outlook to $380M-$400M, Shares Surge
NGVT sits 78% above its 52-week low of $39.735.
Summary
Ingevity raised its full-year 2026 adjusted EBITDA guidance to $380 million to $400 million, a material increase signaling stronger operational performance or improved market conditions. The company also reported Q2 adjusted EPS that beat estimates, contributing to the raised annual outlook. This follows a mixed Q1 where net sales rose 4% to $258 million and the company completed strategic divestitures and a BASF settlement. With a market cap around $2.5 billion, the raised forecast directly impacts earnings expectations and could drive upward revisions. The stock is likely to react positively as traders reprice for higher profitability. Watch for management commentary on the drivers—whether cost savings, volume growth, or pricing—in upcoming filings or calls.
At the time of this announcement, NGVT was trading at $70.62 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $39.74 to $79.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.